facebook twitter instagram linkedin google youtube vimeo tumblr yelp rss email podcast phone blog external search brokercheck brokercheck Play Pause
%POST_TITLE% Thumbnail

Myles Zyblock: US-Iran Escalation

Protection Wealth Lifestyle Updates

US-Iran Escalation

Tensions surrounding the U.S. and Iran have escalated further following reports that President Trump ordered an airstrike in Baghdad that resulted in the death of Iranian General Qassem Soleimani. Middle East experts view this latest action as the most dramatic since the standoff in May.  As a result, there have been calls by global leaders for calm and restraint but all sides, especially for the U.S. and its regional allies, are on high alert for retaliation by Iran. Further complicating matters was that an Iraqi militia leader, Abu Mahdi al-Muhandis was also killed in the airstrike, prompting Iraqi Prime Minister Adil Abdul-Mahdi’s to proclaim the attack as an “aggression against the Iraqi state, government and people”.

 What happens next? While we do not have a definite answer, the potential for further escalation in the region of tit-for-tat actions raises a red flag for a path to war. This concern appears to be broadly shared by our colleagues as overnight, we received several inquiries about what would happen to markets in the event of a U.S.-Iran war.

 Looking at a sample of past U.S. wars and conflicts, we find some interesting data points:

  1. The typical sell-off is relatively shallow at 6.3%. The range is from -2.8% for the recent airstrike in Syria in 2017, to -12.9% around the Korean war.
  2. The duration of the sell-off is short lived. The median number of days of the sell-off is 17 while it takes roughly an equal amount of time to recover at 16 days.
  3. Lastly, 80% of the time, the market is up in the subsequent three months and 93% of the time in the following 12-months.     
cid:image001.png@01D5C225.761BF5A0


This publication contains opinions of the writer and may not reflect opinions of Manulife Securities Incorporated.  The information contained herein was obtained from sources believed to be reliable, but no representation, or warranty, express or implied, is made by the writer or Manulife Securities Incorporated or any other person as to its accuracy, completeness or correctness. This publication is not an offer to sell or a solicitation of an offer to buy any of the securities. The securities discussed in this publication may not be eligible for sale in some jurisdictions. If you are not a Canadian resident, this report should not have been delivered to you. This publication is not meant to provide legal or account advice. As each situation is different you should consult your own professional Advisors for advice based on your specific circumstances.
 This publication is solely the work of Paul Polyviou for the private information of his/her clients. Although the author is a Manulife Securities Advisor, he/she is not a financial analyst at Manulife Securities Incorporated (“Manulife Securities”). This is not an official publication of Manulife Securities. The views, opinions and recommendations are those of the author alone and they may not necessarily be those of Manulife Securities. This publication is not an offer to sell or a solicitation of an offer to buy any securities. This publication is not meant to provide legal, accounting or account advice. As each situation is different, you should seek advice based on your specific circumstances. Please call to arrange for an appointment. The information contained herein was obtained from sources believed to be reliable; however, no representation or warranty, express or implied, is made by the writer, Manulife Securities or any other person as to its accuracy, completeness or correctness.